• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

惊恐障碍中的血清素:血小板摄取与浓度

Serotonin in panic disorder: platelet uptake and concentration.

作者信息

McIntyre I M, Judd F K, Burrows G D, Norman T R

机构信息

Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Vic., Australia.

出版信息

Int Clin Psychopharmacol. 1989 Jan;4(1):1-6. doi: 10.1097/00004850-198901000-00001.

DOI:10.1097/00004850-198901000-00001
PMID:2592755
Abstract

Platelet serotonin uptake and platelet serotonin concentrations were measured in 17 patients (5 males, 12 females) with panic attacks and 15 controls (8 males, 7 females). Higher Vmax values were found in the patient group compared with controls (65 +/- 7 vs. 47 +/- 3 pmol/10(8) platelets/min; p less than 0.05) while the affinity constant Km was not significantly different (0.6 +/- 0.1 vs. 0.5 +/- 0.1 microM). Platelet serotonin concentrations were not significantly different between the two groups (38 +/- 4 vs. 41 +/- 4 ng/10(8) platelets). These results confirm our earlier finding of increased serotonin uptake in patients with panic attacks and suggest that platelet serotonin levels are normal.

摘要

对17名恐慌症患者(5名男性,12名女性)和15名对照者(8名男性,7名女性)测量了血小板5-羟色胺摄取量和血小板5-羟色胺浓度。与对照组相比,患者组的Vmax值更高(65±7对47±3 pmol/10⁸血小板/分钟;p<0.05),而亲和常数Km无显著差异(0.6±0.1对0.5±0.1 microM)。两组之间的血小板5-羟色胺浓度无显著差异(38±4对41±4 ng/10⁸血小板)。这些结果证实了我们早期关于恐慌症患者5-羟色胺摄取增加的发现,并表明血小板5-羟色胺水平正常。

相似文献

1
Serotonin in panic disorder: platelet uptake and concentration.惊恐障碍中的血清素:血小板摄取与浓度
Int Clin Psychopharmacol. 1989 Jan;4(1):1-6. doi: 10.1097/00004850-198901000-00001.
2
Platelet serotonin uptake in panic disorder.惊恐障碍中的血小板5-羟色胺摄取
J Affect Disord. 1986 Jul-Aug;11(1):69-72. doi: 10.1016/0165-0327(86)90062-5.
3
Platelet serotonin uptake in panic disorder patients: a replication study.惊恐障碍患者的血小板5-羟色胺摄取:一项重复研究。
Psychiatry Res. 1989 Oct;30(1):63-8. doi: 10.1016/0165-1781(89)90172-8.
4
Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.惊恐障碍中血小板5-羟色胺摄取:与正常对照的比较及治疗效果
Aust N Z J Psychiatry. 1988 Dec;22(4):390-5. doi: 10.3109/00048678809161347.
5
Platelet serotonin uptake and 3H-imipramine binding in panic disorder.惊恐障碍中的血小板5-羟色胺摄取及3H-丙咪嗪结合
J Affect Disord. 1989 Jul-Aug;17(1):77-81. doi: 10.1016/0165-0327(89)90026-8.
6
Platelet serotonin levels in panic disorder.惊恐障碍中的血小板血清素水平。
Acta Psychiatr Scand. 1987 Mar;75(3):315-7. doi: 10.1111/j.1600-0447.1987.tb02794.x.
7
Differential 3H-imipramine platelet binding in patients with panic disorder and depression.惊恐障碍和抑郁症患者中3H-丙咪嗪血小板结合的差异
Psychiatry Res. 1987 May;21(1):33-41. doi: 10.1016/0165-1781(87)90059-x.
8
Serotonin uptake in panic disorder and agoraphobia.惊恐障碍和广场恐惧症中的血清素摄取
Neuropsychopharmacology. 1988 May;1(2):173-6. doi: 10.1016/0893-133x(88)90010-3.
9
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
Psychopharmacology (Berl). 1990;102(1):85-94. doi: 10.1007/BF02245749.
10
High-affinity platelet [3H]LSD binding is decreased in panic disorder.惊恐障碍患者中高亲和力血小板[3H]麦角酸二乙酰胺结合能力降低。
J Affect Disord. 1990 Jun;19(2):119-23. doi: 10.1016/0165-0327(90)90016-2.

引用本文的文献

1
Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview.《精神疾病诊断与统计手册》第5版焦虑症的外周生物标志物:最新综述
Brain Sci. 2020 Aug 17;10(8):564. doi: 10.3390/brainsci10080564.
2
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.焦虑症、强迫症和创伤后应激障碍的生物标志物:共识声明。第二部分:神经化学、神经生理学和神经认知。
World J Biol Psychiatry. 2017 Apr;18(3):162-214. doi: 10.1080/15622975.2016.1190867. Epub 2016 Jul 15.
3
Panic disorder. Pathophysiology and drug treatment.
Drugs. 1995 Mar;49(3):328-44. doi: 10.2165/00003495-199549030-00002.